These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8273600)

  • 1. PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. II. Effects on nucleoside catabolism in human and rat blood in vitro.
    Dong MK; Gilbertsen RB
    Agents Actions; 1993; 39 Spec No():C99-101. PubMed ID: 8273600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. I. Suppression of the human mixed lymphocyte reaction (MLR).
    Wilburn DJ; Dong MK; Gilbertsen RB
    Agents Actions; 1993; 39 Spec No():C96-8. PubMed ID: 8273599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro and in vivo activities of two 9-deazaguanine analog inhibitors of purine nucleoside phosphorylase, CI-972 and PD 141955.
    Gilbertsen RB; Josyula U; Sircar JC; Dong MK; Wu WS; Wilburn DJ; Conroy MC
    Biochem Pharmacol; 1992 Sep; 44(5):996-9. PubMed ID: 1530667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrrolo[3,2-d]pyrimidines, a new class of purine nucleoside phosphorylase (PNP) inhibitors as potential T-cell selective immunosuppressive agents.
    Sircar JC; Kostlan CR; Gilbertsen RB; Dong MK; Cetenko WA
    Adv Exp Med Biol; 1991; 309A():45-8. PubMed ID: 1789265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of human purine nucleoside phosphorylase. Synthesis of pyrrolo[3,2-d]pyrimidines, a new class of purine nucleoside phosphorylase inhibitors as potentially T-cell selective immunosuppressive agents. Description of 2,6-diamino-3,5-dihydro-7-(3-thienylmethyl)-4H-pyrrolo[3,2-d] pyrimidin-4-one.
    Sircar JC; Kostlan CR; Gilbertsen RB; Bennett MK; Dong MK; Cetenko WJ
    J Med Chem; 1992 May; 35(9):1605-9. PubMed ID: 1578487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of nucleoside degradation in monkey whole blood in vitro by CI-1000, a purine nucleoside phosphorylase (PNP) inhibitor.
    Gilbertsen RB; Dong MK
    Adv Exp Med Biol; 1994; 370():167-71. PubMed ID: 7660883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Amino-9-substituted guanines: potent purine nucleoside phosphorylase (PNP) inhibitors.
    Sircar JC; Kostlan CR; Pinter GW; Suto MJ; Bobovski TP; Capiris T; Schwender CF; Dong MK; Scott ME; Bennett MK
    Agents Actions; 1987 Aug; 21(3-4):253-6. PubMed ID: 3120506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and pharmacological properties of CI-972, a novel 9-deazaguanine analog purine nucleoside phosphorylase (PNP) inhibitor.
    Gilbertsen RB; Dong MK; Wilburn DJ; Kossarek LM; Sircar JC; Kostlan CR; Conroy MC
    Adv Exp Med Biol; 1991; 309A():41-4. PubMed ID: 1789255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of two 9-deazaguanine analogue inhibitors of purine nucleoside phosphorylase, CI-972 and PD 141955, in vitro and in vivo.
    Gilbertsen RB; Dong MK; Josyula U; Sircar JC; Wilburn DJ; Conroy MC
    Ann N Y Acad Sci; 1993 Jun; 685():248-51. PubMed ID: 8363228
    [No Abstract]   [Full Text] [Related]  

  • 10. A purine nucleoside phosphorylase (PNP) inhibitor induces apoptosis via caspase-3-like protease activity in MOLT-4 T cells.
    Posmantur R; Wang KK; Nath R; Gilbertsen RB
    Immunopharmacology; 1997 Oct; 37(2-3):231-44. PubMed ID: 9403342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary report on 8-amino-9-(2-thienylmethyl)guanine (PD 119,229), a novel and potent purine nucleoside phosphorylase inhibitor.
    Gilbertsen RB; Scott ME; Dong MK; Kossarek LM; Bennett MK; Schrier DJ; Sircar JC
    Agents Actions; 1987 Aug; 21(3-4):272-4. PubMed ID: 3120507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a pathway independent from 2'-deoxyguanosine and reversible by IL-2 by which purine nucleoside phosphorylase inhibitors block T-cell proliferation.
    Boehncke WH; Gilbertsen RB; Hemmer J; Sterry W
    Scand J Immunol; 1994 Mar; 39(3):327-32. PubMed ID: 8128192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective in vitro inhibition of human MOLT-4 T lymphoblasts by the novel purine nucleoside phosphorylase inhibitor, CI-972.
    Gilbertsen RB; Dong MK; Kossarek LM; Sircar JC; Kostlan CR; Conroy MC
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1351-8. PubMed ID: 1908235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine nucleoside phosphorylase inhibitors: biochemical and pharmacological studies with 9-benzyl-9-deazaguanine and related compounds.
    Bennett LL; Allan PW; Noker PE; Rose LM; Niwas S; Montgomery JA; Erion MD
    J Pharmacol Exp Ther; 1993 Aug; 266(2):707-14. PubMed ID: 8355201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design of inhibitors of purine nucleoside phosphorylase. 2. 9-Alicyclic and 9-heteroalicyclic derivatives of 9-deazaguanine.
    Secrist JA; Niwas S; Rose JD; Babu YS; Bugg CE; Erion MD; Guida WC; Ealick SE; Montgomery JA
    J Med Chem; 1993 Jun; 36(13):1847-54. PubMed ID: 8515423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of human purine nucleoside phosphorylase. Synthesis, purine nucleoside phosphorylase inhibition, and T-cell cytotoxicity of 2,5-diaminothiazolo[5,4-d]pyrimidin-7(6H)-one and 2,5-diaminothiazolo[4,5-d]pyrimidin-7(6H)-one. Two thio isosteres of 8-aminoguanine.
    Sircar JC; Suto MJ; Scott ME; Dong MK; Gilbertsen RB
    J Med Chem; 1986 Sep; 29(9):1804-6. PubMed ID: 3091835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
    Dong MK; Scott ME; Schrier DJ; Suto MJ; Sircar JC; Black A; Chang T; Gilbertsen RB
    J Pharmacol Exp Ther; 1992 Jan; 260(1):319-26. PubMed ID: 1530976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro pharmacologic activity of the purine nucleoside phosphorylase inhibitor BCX-34: the role of GTP and dGTP.
    Bantia S; Montgomery JA; Johnson HG; Walsh GM
    Immunopharmacology; 1996 Oct; 35(1):53-63. PubMed ID: 8913795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biochemical and pharmacological activity of 9-benzyl-9-deazaguanine, a potent purine nucleoside phosphorylase (PNP) inhibitor.
    Kimble E; Hadala J; Ludewig R; Peters P; Greenberg G; Xiao G; Guida W; McQuire L; Simon P
    Inflamm Res; 1995 Aug; 44 Suppl 2():S181-2. PubMed ID: 8548387
    [No Abstract]   [Full Text] [Related]  

  • 20. Potentiation of 2'-deoxyguanosine cytotoxicity by a novel inhibitor of purine nucleoside phosphorylase, 8-amino-9-benzylguanine.
    Shewach DS; Chern JW; Pillote KE; Townsend LB; Daddona PE
    Cancer Res; 1986 Feb; 46(2):519-23. PubMed ID: 3079664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.